PINK1

PINK1. PTEN-induced putative kinase 1 is a serine/threonine kinase encoded by the PARK6 gene locus, crucial for maintaining mitochondrial quality control. Its primary function is to sense mitochondrial depolarization and initiate a protective pathway known as mitophagy to remove damaged organelles. Mutations in the gene are a significant cause of early-onset autosomal recessive Parkinson's disease, linking mitochondrial dysfunction directly to neurodegeneration.

Function and mechanism

PINK1 functions as a central sensor of mitochondrial health within the eukaryotic cell. Under normal conditions with a healthy mitochondrial membrane potential, PINK1 is imported into the inner mitochondrial membrane, cleaved by proteases like PARL, and rapidly degraded by the proteasome. When mitochondria are damaged and the membrane potential collapses, this import fails, leading to PINK1 stabilization on the outer mitochondrial membrane. Here, it undergoes autophosphorylation and recruits the E3 ubiquitin ligase Parkin from the cytosol. PINK1 then phosphorylates both ubiquitin and Parkin, activating the ligase to ubiquitinate numerous outer membrane proteins. This extensive polyubiquitination acts as an "eat-me" signal, recruiting autophagy adaptors like OPTN and NDP52 to initiate the encapsulation of the damaged mitochondrion by an autophagosome for lysosomal degradation.

Role in Parkinson's disease

The critical role of PINK1 in neuronal survival was established with the discovery that loss-of-function mutations cause a hereditary form of Parkinson's disease. This places PINK1 within a pathway involving other Parkinson's disease genes such as PRKN, DJ-1, and LRRK2. In dopaminergic neurons of the substantia nigra, which have high energy demands, failure of the PINK1-Parkin pathway leads to the accumulation of dysfunctional mitochondria. This results in bioenergetic failure, increased reactive oxygen species production, and ultimately apoptosis. Studies in model organisms like Drosophila melanogaster and Mus musculus have shown that PINK1 deficiency leads to motor defects and mitochondrial morphology abnormalities, phenotypes that can be rescued by expression of wild-type PINK1 or Parkin.

Gene and protein structure

The PINK1 gene is located on the short arm of chromosome 1 (1p36.12) and consists of eight exons spanning approximately 1.8 kilobases. It encodes a 581-amino acid protein with a predicted molecular mass of ~63 kDa. The protein structure includes an N-terminal mitochondrial targeting sequence, a transmembrane domain that anchors it to the mitochondria, and a highly conserved serine/threonine kinase domain with homology to the Ca2+/calmodulin-dependent protein kinase family. Key functional residues, such as the ATP-binding site and the activation loop, are critical for its catalytic activity. Disease-associated mutations, like the common G309D and L347P variants, often cluster within this kinase domain, impairing its enzymatic function.

Regulation and interactions

PINK1 activity is tightly regulated through multiple post-translational modifications and protein interactions. Its turnover is controlled by the presenilin-associated rhomboid-like protease and the AAA+ protease AFG3L2. Beyond its primary partnership with Parkin, PINK1 interacts with the TOM complex for mitochondrial import and with the HtrA2 protease, another protein linked to Parkinson's disease. It also phosphorylates components of the MIRO-TRAK complex on the outer membrane, which halts mitochondrial motility to isolate damaged organelles. Furthermore, PINK1 can influence broader cellular processes by modulating Bcl-2 family member activity and interacting with Beclin-1, thereby linking mitochondrial quality control to general autophagy and apoptosis pathways.

Clinical significance and research

PINK1 represents a major therapeutic target for Parkinson's disease, with research focused on developing kinase activators or compounds that can bypass its function to induce mitophagy. Biomarkers of PINK1 activity are being explored in cerebrospinal fluid and peripheral blood mononuclear cells. Investigations extend beyond neurodegeneration, as PINK1 dysfunction is implicated in other conditions like cancer, cardiac ischemia, and diabetic cardiomyopathy, highlighting its role in general cellular stress responses. Current research utilizes advanced models including induced pluripotent stem cell-derived neurons, C. elegans, and non-human primates to further elucidate its pathophysiology and test potential gene therapy or pharmacological chaperone strategies. Category:Genes Category:Parkinson's disease Category:Mitochondrial proteins